ARTICLE | Clinical News
Etubics preclinical data
April 15, 2013 7:00 AM UTC
In mice with HPV-expressing tumors, Etubic's HPV 16 E6/E7 vaccine plus cisplatin and radiation significantly improved survival vs. null vector-treated controls (p=0.029). The vaccine comprises an aden...